Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

News und Analysen

DGAP-News: RHÖN-KLINIKUM AG Confirms Guidance for 2019 Following Increase in Revenues in the Third Quarter and in the First Nine Months: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23735/Rhoen-klinikum.svg.png
DGAP-News: RHÖN-KLINIKUM AG Confirms Guidance for 2019 Following Increase in Revenues in the Third Quarter and in the First Nine Months
DGAP-News: RHÖN-KLINIKUM AG Confirms Guidance for 2019 Following Increase in Revenues in the Third Quarter and in the First Nine Months
DGAP-News: RHÖN-KLINIKUM AG: Supervisory Board Approves to Establish Medgate Deutschland GmbH: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23735/Rhoen-klinikum.svg.png
DGAP-News: RHÖN-KLINIKUM AG: Supervisory Board Approves to Establish Medgate Deutschland GmbH
DGAP-News: RHÖN-KLINIKUM AG: Supervisory Board Approves to Establish Medgate Deutschland GmbH
DGAP-News: RHÖN-KLINIKUM AG: Aufsichtsrat stimmt Gründung von Medgate Deutschland GmbH zu : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23735/Rhoen-klinikum.svg.png
DGAP-News: RHÖN-KLINIKUM AG: Aufsichtsrat stimmt Gründung von Medgate Deutschland GmbH zu
DGAP-News: RHÖN-KLINIKUM AG: Aufsichtsrat stimmt Gründung von Medgate Deutschland GmbH zu
DGAP-News: RHÖN-KLINIKUM AG: project consortium receives Euro 3.8 million from the Innovation Fund of the Federal Joint Committee for improving the link between the different medical services for the treatment of patients with cardiac insufficiency: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23735/Rhoen-klinikum.svg.png
DGAP-News: RHÖN-KLINIKUM AG: project consortium receives Euro 3.8 million from the Innovation Fund of the Federal Joint Committee for improving the link between the different medical services for the treatment of patients with cardiac insufficiency
DGAP-News: RHÖN-KLINIKUM AG: project consortium receives Euro 3.8 million from the Innovation Fund of the Federal Joint Committee for improving the link between the different medical services for the treatment of patients with cardiac insufficiency
DGAP-News: RHÖN-KLINIKUM AG: Projektkonsortium erhält 3,8 Mio. Euro vom Innovationsfonds des G-BA für eine besser verzahnte Behandlung von Patienten mit Herzinsuffizienz und die Entwicklung eines regionalen Vergütungsmodells: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23735/Rhoen-klinikum.svg.png
DGAP-News: RHÖN-KLINIKUM AG: Projektkonsortium erhält 3,8 Mio. Euro vom Innovationsfonds des G-BA für eine besser verzahnte Behandlung von Patienten mit Herzinsuffizienz und die Entwicklung eines regionalen Vergütungsmodells
DGAP-News: RHÖN-KLINIKUM AG: Projektkonsortium erhält 3,8 Mio. Euro vom Innovationsfonds des G-BA für eine besser verzahnte Behandlung von Patienten mit Herzinsuffizienz und die Entwicklung eines regionalen Vergütungsmodells
DGAP-News: Gerresheimer AG: Gerresheimer treibt Wachstums- und Technologieprojekte im dritten Quartal voran: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
DGAP-News: Gerresheimer AG: Gerresheimer treibt Wachstums- und Technologieprojekte im dritten Quartal voran
DGAP-News: Gerresheimer AG: Gerresheimer treibt Wachstums- und Technologieprojekte im dritten Quartal voran
DGAP-News: Gerresheimer AG: Gerresheimer advances growth and technology projects in third quarter: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
DGAP-News: Gerresheimer AG: Gerresheimer advances growth and technology projects in third quarter
DGAP-News: Gerresheimer AG: Gerresheimer advances growth and technology projects in third quarter
EQS-News: First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23735/Rhoen-klinikum.svg.png
EQS-News: First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed
EQS-News: First half of 2024: RHÖN-KLINIKUM AG continues good business performance – outlook confirmed
Why Integra Lifesciences Stock Is Sinking Today: https://g.foolcdn.com/editorial/images/785027/surgery.jpg
Why Integra Lifesciences Stock Is Sinking Today

Shares of Integra Lifesciences (NASDAQ: IART) were sinking 15.5% as of 11 a.m. ET on Monday. The decline came after the medical technology company announced its second-quarter results before the

Why Arm Holdings Stock Is Jumping Today: https://g.foolcdn.com/editorial/images/784306/gettyimages-2148797906.jpg
Why Arm Holdings Stock Is Jumping Today

Arm Holdings (NASDAQ: ARM) stock is advancing in Tuesday's trading. The semiconductor company's share price was up 5% as of 3 p.m. ET, according to data from S&P Global Market Intelligence.

While

EQS-News: Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive: https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-News: Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive
EQS-News: Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive
EQS-Adhoc: Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024: https://www.sharewise.com/rails/active_storage/blobs/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBhQT09IiwiZXhwIjpudWxsLCJwdXIiOiJibG9iX2lkIn19--b12b7dfadf2c58d9e1a19e072122a740f7f20d88/Sartorius.svg?locale=us
EQS-Adhoc: Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024
EQS-Adhoc: Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024
EQS-News: Gerresheimer remains on track in 1st half year 2024: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-News: Gerresheimer remains on track in 1st half year 2024
EQS-News: Gerresheimer remains on track in 1st half year 2024
EQS-News: Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret
EQS-News: Sartorius AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office – Supervisory Board expresses great regret
EQS-Adhoc: SARTORIUS AG: After more than 20 years as CEO,  Joachim Kreuzburg will not pursue another term in office : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-Adhoc: SARTORIUS AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office
EQS-Adhoc: SARTORIUS AG: After more than 20 years as CEO, Joachim Kreuzburg will not pursue another term in office
EQS-News: Gerresheimer expands capacities for Medical Systems in the USA: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-News: Gerresheimer expands capacities for Medical Systems in the USA
EQS-News: Gerresheimer expands capacities for Medical Systems in the USA
EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
EQS-News: Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
EQS-News: Sartorius to advance drug discovery and manufacturing with AI in collaboration with NVIDIA
EQS-News: Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
EQS-News: Sartorius collaborates with Sanofi to commercialize end-to-end platform for downstream process intensification
EQS-News: RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter : http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23735/Rhoen-klinikum.svg.png
EQS-News: RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter
EQS-News: RHÖN-KLINIKUM AG starts financial year 2024 with a good first quarter
Geisinger and Acadia Healthcare Hold Groundbreaking Ceremony for New Behavioral Health Hospital in Danville: https://mms.businesswire.com/media/20240506592018/en/2123321/5/Acadia_GB5775_photo.jpg
Geisinger and Acadia Healthcare Hold Groundbreaking Ceremony for New Behavioral Health Hospital in Danville


Geisinger and Acadia Healthcare Company held a ceremony today to celebrate the start of construction on its previously announced state-of-the-art, 96-bed behavioral health hospital in Danville

EQS-News: Gerresheimer partners with RxCap to offer connected adherence solutions: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/23715/Gerresheimer_logo.svg.png
EQS-News: Gerresheimer partners with RxCap to offer connected adherence solutions
EQS-News: Gerresheimer partners with RxCap to offer connected adherence solutions
EQS-News: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed: http://s3-eu-west-1.amazonaws.com/sharewise-dev/attachment/file/24067/Sartorius.svg.png
EQS-News: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
EQS-News: Sartorius: First quarter results in line with expectations; recurring business with significant order growth; demand from China remains weak; outlook for full year confirmed
Agave Ridge Behavioral Hospital Hosts Ceremony to Celebrate Grand Opening: https://mms.businesswire.com/media/20240411986178/en/2096213/5/ACHC_Agave_Ridge_Mesa_Photo.jpg
Agave Ridge Behavioral Hospital Hosts Ceremony to Celebrate Grand Opening


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced the opening of its newest acute care hospital, Agave Ridge Behavioral Hospital, located at 3322 S. Ellsworth Road, in Mesa, Arizona. A